Welcome to our dedicated page for Mountain Vy Md news (Ticker: MVMDF), a resource for investors and traders seeking the latest updates and insights on Mountain Vy Md stock.
Mountain Valley MD Holdings Inc. (MVMDF) features regularly in corporate news for its progress across three stated business lines: nutraceuticals using its patented Quicksome™ oral formulation technology, husbandry animal and aquatic applications based on its Quicksol™ solubility platform, and agricultural initiatives centered on the licensed Agrarius™ plant signaling technology. Company updates often detail commercialization milestones, licensing agreements, and field trial results.
News releases describe how Mountain Valley MD works with a U.S.-based GMP manufacturing partner to produce Quicksome™-powered sublingual nutraceutical products for licensees and for its proprietary “Mountains Of…” brand. Coverage includes product launches and formulation work for categories such as sleep, energy, immunity, stress and anxiety support, and other wellness-focused applications.
In agriculture, the company’s news flow highlights its exclusive license to sell Agrarius™ across North America, Mexico, Central America, South America, and the Caribbean, along with extensive crop trials and a Performance Guarantee Program under which clients pay only if defined yield or plant health thresholds are met. Updates frequently summarize trial outcomes in crops like citrus, corn, sugarcane, soybeans, potatoes, cotton, and pasture grass, as well as regulatory and registration progress in various jurisdictions.
For husbandry animals and aquatic species, Mountain Valley MD reports on the development and licensing of Soluvec™ 1%, a Quicksol™-based ivermectin formulation, including agreements with partners such as a Bangladesh licensee. Investors and observers can use this news page to follow the company’s reported commercialization steps, partnership developments, and technology validation efforts over time.
Mountain Valley MD (OTCQB: MVMDF) provided a year-end business update on December 24, 2025, reporting commercialization progress across three platforms: Quicksome nutraceutical delivery, Agrarius agricultural plant signaling, and Quicksol/Soluvec for husbandry and aquaculture.
Key disclosed outcomes include scaled production and retail activity for Quicksome-based nutraceuticals, multiple Agrarius trials showing double-digit yield gains in citrus and row crops, and Soluvec 1% demonstrating nine-month stability but limited royalty revenue to date.
Mountain Valley MD (OTC:MVMDF) reported positive Agrarius agricultural trial results from Brazil and Colombia on December 1, 2025, showing measurable yield and plant‑health gains across multiple crops. Key highlights include a 49% yield increase in Valencia oranges and ~15% (125 boxes/ha) improvement in Hamlin oranges, plus observed reduction in visible HLB symptoms. Potato trials showed 18.49% higher productivity; corn trials reported 14.8% and 11.2% gains. Colombian pasture trials demonstrated improved regrowth and nutritional quality, with final analysis expected in early 2026. The company positions Agrarius for scaled commercialization across citrus, row crops, and forage systems.
Mountain Valley MD (OTCQB:MVMDF) provided a comprehensive business update across its three core technology divisions. The company's Quicksome™ nutraceutical division reported progress with its U.S.-based GMP manufacturer, including USD $193,000 in Q2 2025 sales through licensee Circadian Wellness Corp.
In agriculture, the company's Agrarius technology demonstrated significant yield improvements in field trials: 14.8% increase in corn yield, 10% in sugarcane, and 18.49% in potatoes. The company expanded trials across multiple crops and secured regulatory approvals in several Latin American countries.
The Soluvec™ 1% division reported production of 200 tonnes of coated fish feed in Bangladesh, though royalty revenues were below expectations due to cyclone impact. MVMD is pursuing patent protection in 12 additional markets and plans expansion into Latin America.
Mountain Valley MD Holdings (OTCQB: MVMDF) has announced changes to its Board of Directors. The company appointed David Batchelor, a seasoned organizational strategist with over 25 years of experience in business transformation and performance improvement.
Batchelor brings extensive experience working with global leaders like Cisco, Coca-Cola, IBM, Merck, Bayer, and Johnson & Johnson. He holds a Master's degree in Distributed Learning and has held faculty positions at Schulich Executive Education Centre and Royal Roads University.
The company also announced the resignations of directors Kevin Puloski and Nancy Richardson. These board changes align with MVMD's focus on growth, commercialization, and disciplined capital deployment.
Mountain Valley MD Holdings (MVMD) provided a year-end update on its commercialization progress across three core areas: Nutraceuticals, Agriculture, and Husbandry Animals/Aquatic Species. In Nutraceuticals, the company advanced its Quicksome™ technology through partnerships and product developments, including an OUD formulation and testosterone products. The agriculture division expanded its Agrarius technology presence, securing registrations in multiple countries and implementing a Performance Guarantee Program. In the Husbandry/Aquatic segment, their Soluvec™ 1% product achieved initial sales of 100 tonnes of coated fish feed in Bangladesh, with manufacturing resuming in November 2024 after cyclone-related disruptions.
Mountain Valley MD Holdings Inc. (MVMD) provided a business update on its three core lines: Nutraceuticals, Agriculture, and Husbandry Animals/Aquatic Species. Key developments include:
1. Nutraceuticals: Completed setup for Quicksome™ technology production. Launched Eons Deeper Sleep product with Circadian Wellness. Internal testing showed improved sleep metrics.
2. Agriculture: Acquired exclusive license for Agrarius agricultural technology in the Americas and Caribbean. Obtained product registration in EU, 44 US states, Canada, and Brazil. Launched Performance Guarantee Program for North American farmers.
3. Husbandry/Aquatic: Developed Soluvec™ 1% (solubilized Ivermectin) for animal applications. Licensed to a partner in Bangladesh for fish feed coating, with shipments planned for Q3 2024.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
FAQ
What is the current stock price of Mountain Vy Md (MVMDF)?
What is the market cap of Mountain Vy Md (MVMDF)?
